Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist
- 1 October 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 285 (2) , 181-188
- https://doi.org/10.1016/0014-2999(95)00401-6
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats.Hypertension, 1992
- Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research.Hypertension, 1991
- DuP 532: A second generation of nonpeptide angiotensin II receptor antagonistsBiochemical and Biophysical Research Communications, 1991
- Severe Angioedema after Long-Term Use of an Angiotensin-Converting Enzyme InhibitorAnnals of Internal Medicine, 1990
- Long-term inhibition of angiotensin converting enzyme suppresses calcium channel agonist-induced contraction of aorta in hypertensive rats.Hypertension, 1989
- Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypothesesJournal Of Hypertension, 1989
- Identification of angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989
- Converting-Enzyme Inhibitors in the Treatment of HypertensionNew England Journal of Medicine, 1988
- Conceptual and Therapeutic Approaches to Inhibition of the Renin-Angiotensin System in Chronic Heart FailureJournal of Cardiovascular Pharmacology, 1986
- A simple and rapid method for the preparation of plasma membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983